Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GN10302 Hypericin

    金丝桃素

    An anthroquinone derivative
  3. GN10103 Neferine

    甲基莲心碱; (-)-Neferine

    Neferine (NEF)是一种从传统中药莲子心分离出来的天然双苄基异喹啉生物碱。Neferine具有多种药理特性。
  4. GN10783 (R) Ginsenoside Rh2

    20(R)-人参皂苷Rh2

    A steroid glycoside with diverse biological activities
  5. GN10802 Brazilin

    巴西苏木素

    A flavonoid with diverse bioactivites
  6. GN10470 Eriodictyol

    圣草酚

    圣草酚是一种从中药中分离出来的黄酮类化合物,具有抗氧化和抗炎活性。
  7. GN10275 Protosappanin B

    原苏木素B(原巴西苏木素),(-)-Protosappanin B

    Protosappanin B 是一种从 Lignum Sappan 中提取的酚类化合物。抗癌活性。 Protosappanin B 在人膀胱癌细胞中诱导细胞凋亡并导致 G1 细胞周期停滞。
  8. GN10151 Geraniin

    老鹳草素

    Geraniin是一种TNF-α释放抑制剂,IC50值为43µM,具有多种活性,包括抗癌、抗炎和抗高血糖活性。
  9. GN10727 Forsythoside B

    连翘酯苷 B

    Forsythoside B是从传统中药植物连翘的叶子中分离的一种苯乙醇苷,具有多种生物活性,能够用于治疗炎症性疾病和促进血液循环。
  10. GN10065 2-Atractylenolide

    苍术内酯 II; Asterolide

    A sesquiterpene with diverse biological activities
  11. GN10394 Atractylenolide III

    白术内酯III,ICodonolactone; 8β-Hydroxyasterolide

    A sesquiterpene with diverse biological activities
  12. GN10732 Oroxin B

    木蝴蝶苷B

    Oroxin B (OB) 是从中草药 Oroxylum indicum (L.) Vent 中分离得到的黄酮类化合物。Oroxin B (OB) 具有明显的抑制作用,通过上调 PTEN、下调 PTEN 诱导肝癌细胞早期凋亡而不是晚期凋亡COX-2、VEGF、PI3K 和 p-AKT.Oroxin B (OB) 在恶性淋巴瘤细胞中选择性诱导肿瘤抑制性 ER 应激。
  13. GN10129 Polyphyllin VII

    重楼皂苷G

    Polyphyllin VII 是从云南巴黎的根茎中分离得到的,具有抗菌和抗癌活性。
  14. GN10650 Ziyuglycoside II

    地榆皂苷II

    Ziyuglycoside II 是一种从地榆中提取的三萜皂苷类化合物。
  15. GN10203 Ziyuglycoside I

    地榆皂苷 I

    A triterpenoid saponin with diverse biological activities
  16. GN10109 Ganoderic Acid A

    灵芝酸 A

    Ganoderic Acid A是一种来源于灵芝(Ganoderma lucidum)的三萜类化合物,具有多种生物活性。
  17. GN10788 Cucurbitacin Ⅱb

    雪胆素乙

    A natural triterpene
  18. GN10639 Methyl protodioscin

    甲基原薯蓣皂甙,NSC-698790; Smilax saponin B

    Methyl protodioscin(NSC-698790) 是一种呋甾二糖苷,具有抗肿瘤特性;显示减少增殖,导致细胞周期停滞。
  19. GN10645 Jaceosidin

    棕矢车菊素

    A natural methylated trihydroxyflavone
  20. GN10040 Dehydrocorydaline

    脱氢紫堇碱; 13-Methylpalmatine

    Dehydrocorydaline是从延胡索中分离得到的一种季铵生物碱。
  21. GN10535 Cucurbitacin B

    葫芦素 B

    A natural triterpene

  22. GN10520 Benzoylpaeoniflorin

    苯甲酰芍药苷

    苯甲酰芍药苷是一种来自中国白芍的天然产物,可通过减少细胞凋亡来治疗冠心病。
  23. GN10560 α-hederin

    ALPHA-常春藤皂甙,α-Hederin

    A triterpenoid saponin with diverse biological activities
  24. GN10531 Dimethylfraxetin

    二甲基白蜡树亭,6,7,8-Trimethoxycoumarin; Fraxetin dimethyl ether

    A coumarin with anti-inflammatory activity
  25. GN10144 Oleandrin

    欧夹竹桃苷; PBI-05204

    A glycoside with diverse biological activities
  26. GN10800 20(S)-NotoginsenosideR2

    三七皂苷R2,20(S)-Notoginsenoside R2; Ginsenoside Ng-R2

    20(S)-NotoginsenosideR2 是一种从三七中新分离的三七皂苷,对 6-OHDA 诱导的氧化应激和细胞凋亡具有神经保护作用。
  27. GN10019 Ginsenoside Rg6

    人参皂苷 Rg6

    Ginsenoside Rg6 抑制 TNF-α 诱导的 NF-κB 转录活性,在 HepG2 细胞中的 IC50 为 29.34 μM。
  28. GN10584 Ginsenoside Rk1

    人参皂苷

    人参皂甙 Rk1 是通过在高温下加工人参植物(主要是 Sung Ginseng,SG)而产生的独特成分 。
  29. GN10462 Pulsatilla saponin D

    白头翁皂苷D; SB365; Hederacolchiside A

    An oleanane-type saponin with anticancer activity
  30. GN10734 Polyphyllin B

    重楼皂苷 II

    Polyphyllin B是巴黎根中最重要的皂苷之一,对多种癌细胞具有毒性作用。 Polyphyllin B 通过激活半胱天冬酶和细胞周期阻滞诱导细胞凋亡。
  31. GN10219 Ciwujianoside-B

    刺五加皂苷 B

    Ciwujianoside-B 是从刺五加叶中分离得到的,口服后能在大脑中渗透和发挥作用。
  32. GN10654 (+)-Corynoline

    紫蓳灵

    An isoquinoline alkaloid with diverse biological activities
  33. GN10249 Polyphyllin VI

    重楼皂苷VI

    Polyphyllin VI是一种具有口服活性的天然皂苷,主要通过诱导细胞周期阻滞、细胞凋亡和细胞焦亡发挥抗癌作用。
  34. GN10709 Polyphyllin A

    重楼皂苷I

    A steroid saponin with anticancer activity
  35. GN10585 Tetramethylpyrazine

    川芎嗪; Chuanxiongzine; Tetramethylpyrazine

    Tetramethylpyrazine是一种从川芎中分离出来的生物碱,具有抗炎、抗氧化、抗肿瘤、自噬调节、血管舒张、血管生成调节、线粒体损伤抑制、内皮保护、神经保护等活性。
  36. GN10778 Picroside II

    胡黄连苷II

    A flavonoid with diverse biological activities
  37. GN10561 astragalin

    紫云英苷; Astragaline; 3-Glucosylkaempferol; Kaempferol 3-β-D-glucopyranoside

    Astragalin是一种具有强抗氧化和抗炎活性的天然黄酮类化合物,在多种疾病(包括癌症和心血管疾病)中显示出潜在的治疗应用价值。
  38. GN10045 Angelicin

    异补骨脂素; Isopsoralen

    A furanocoumarin with antibacterial activities
  39. GN10453 Ginkgolide B

    银杏内酯 B; 白果苦内酯 B; BN-52021

    Ginkgolide B是从银杏叶中提取的一种萜内酯,是血小板活化因子(PAF)的特异性拮抗剂, IC50为 3.6μM。
  40. GN10457 Oleuropein

    橄榄苦苷

    Oleuropein是橄榄树中的主要酚类化合物,具有强效的抗氧化和抗炎特性。
  41. GN10429 Neochlorogenic acid

    新绿原酸; trans-5-O-Caffeoylquinic acid

    A phenolic compound with diverse biological activities
  42. GN10248 Hesperitin

    橙皮素

    A hypocholesterolemic citrus flavonoid
  43. GN10634 Myricetin

    杨梅素; Cannabiscetin; 杨梅酮

    Myricetin是一种常见于植物且具有抗氧化、抗炎和抗肿瘤活性的天然黄酮类化合物,是丝裂原活化蛋白激酶激酶(MEK1)和 JB6 P+小鼠表皮细胞转化的新型抑制剂。
  44. GN10415 Astilbin

    落新妇苷

    A flavonoid with diverse biological activities
  45. GN10370 Luteolin

    木犀草素; Luteoline; Luteolol; Digitoflavone

    木犀草素(Luteolin)是一种黄酮类化合物,具有抗炎、抗氧化、抗癌等多种功能。Luteolin是一种有效的核因子红细胞2相关因子2(Nrf2)抑制剂。
  46. GN10388 Gallic acid

    没食子酸; 3,4,5-Trihydroxybenzoic acid

    A phenol with diverse biological activities
  47. GN10333 Osthole

    蛇床子素; Osthol; NSC 31868

    A coumarin with diverse biological activities
  48. GN10127 Salidroside

    红景天苷; Rhodioloside

    红景天苷是一种具有多种生物活性的糖苷,具有抗癌、抗氧化、抗衰老、抗糖尿病、抗糖尿病、抗高血压、抗炎、免疫调节等药理作用。
  49. GN10321 Glycitein

    黄豆黄素; Glycetein

    A major isoflavone
  50. GN10331 Polydatin

    虎杖苷; Piceid; 反式虎杖苷

    Polydatin是从传统中药Polygonum cuspidatum中提取的一种天然二苯乙烯类葡萄糖苷,是白藜芦醇的糖苷形式。
  51. GN10648 Rosmarinic acid

    迷迭香酸; Labiatenic acid

    Rosmarinic acid是一种广泛存在于植物中的酚酯化合物。Rosmarinic acid具有抗病毒、抗菌、抗炎、神经保护、抗癌、抗脂质过氧化、细胞凋亡和抗氧化活性。

Items 2601 to 2650 of 2721 total

per page

Set Descending Direction